Psychedelics can change humanity for the better. It’s time to unlock their power

Studies of MDMA, ketamine, psilocybin mushrooms and other psychedelics have shown tremendous potential for therapeutic applications.

 Wall Street Backs New Class of Psychedelic Drugs

Psychedelic-therapy industry gets a reality trip as investors focus on treatments costing less time and money.

Big Pharma Is Betting on Psychedelics for Mental Health

Psychedelic drugs are still classified as Schedule 1 drugs, or drugs with no current accepted medical use and a high potential for abuse. But as regulations around these drugs are beginning to loosen, they’re becoming accepted treatments for a host of mental health issues—and fueling what many call a psychedelic renaissance.

Do Psychedelics Drive You Crazy Or Keep You Sane?

For antiprohibitionists who are wondering what comes next after marijuana legalization, this class of drugs seems like a good place to start.

Hallucinogens Have Doctors Tuning In Again

Scientists are taking a new look at hallucinogens, which became taboo among regulators after enthusiasts like Timothy Leary promoted them in the 1960s with the slogan “Turn on, tune in, drop out.”

How Psychedelics Became the New Club Drug

With psychedelic drugs becoming more socially acceptable, taking them in the club also feels less dangerous. “People used to be very careful because they were scared of tripping,” says Nabben. “But now they’re experimenting with smaller doses, which allows them to use them in different settings. These doses can be combined with other substances, too.”

My Nutmeg Bender

As it turns out, nutmeg contains a psychoactive element called myristicin, whose chemical structure shares similarities with mescaline, amphetamine, and ecstasy. A Dictionary of Hallucinations—let us pause for a moment to give thanks that we live in a world where such a reference exists—notes that nutmeg has been “reported to mediate visual, auditory, tactile, and kinaesthetic hallucinations (notably the sensation of floating).” This is not breaking news: the Benedictine abbess Hildegard of Bingen noted the mind-altering effects of nutmeg all the way back in the 12th century.

Psychedelics May Be Part of U.S. Medicine Sooner Than You Think

It came as a surprise to many when, on Feb. 3, Australian regulators announced that medicines containing the psychedelic substances MDMA and psilocybin can soon be used there to treat post-traumatic stress disorder (PTSD) and treatment-resistant depression, respectively. That decision makes Australia the first country in the world to formally recognize the therapeutic use of psychedelics. Other countries, including the U.S., may be headed toward a similar outcome, some experts say.

Psychedelics Open Your Brain. You Might Not Like What Falls In

Reshaping your mind isn’t always a great idea.

Study Reveals More People are Using Psychedelics to Self-Treat Mental Health

The numbers indicate a growing movement of people unwilling to wait for LSD and psilocybin to be legalised.

The fascinating, strange medical potential of psychedelic drugs, explained in 50+ studies

One reason psychedelics may work: They treat the person’s context, not just their illness.

The most convincing argument for legalizing LSD, shrooms, and other psychedelics

As hallucinogens get a renewed look by researchers, they're finding that the substances may improve almost anyone's mood and quality of life — as long as they're taken in the right setting, typically a controlled environment.

The New Psychedelic Plot

With popular drugs like ketamine and psilocybin making their way into recent stories and novels, altering characters, expediting climaxes and dictating narratives, is fiction changing forever?

The Rise of Psychedelic Retreats

Even with cause for concern, retreats in countries like Costa Rica and Jamaica, as well as in the United States, have been popping up for more than a decade.

Use of Marijuana and Psychedelics Is Soaring Among Young Adults, Study Finds

The annual U.S. survey of substance use captures the growing mainstream acceptance of cannabis and hallucinogenic compounds.